danthron has been researched along with anthrone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 1 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gawlik, I; Huang, HS; Müller, K; Prinz, H; Ziereis, K | 1 |
| Breu, K; Müller, K; Reindl, H | 1 |
| Bergonzi, MC; Bilia, AR; Bindoli, A; Chioccioli, M; Gabbiani, C; Gratteri, P; Karioti, A; Messori, L; Rigobello, MP; Scutari, G; Sorrentino, F | 1 |
| Lefin, R; Petzer, A; Petzer, JP | 1 |
| MUHLEMANN, H | 1 |
5 other study(ies) available for danthron and anthrone
| Article | Year |
|---|---|
Simple analogues of anthralin: unusual specificity of structure and antiproliferative activity.
Topics: Administration, Topical; Animals; Anthralin; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Arachidonate 5-Lipoxygenase; Cattle; Cell Division; Humans; Keratinocytes; Leukocytes, Mononuclear; Lipoxygenase Inhibitors; Oxidants; Psoriasis; Sensitivity and Specificity; Structure-Activity Relationship | 1997 |
Antipsoriatic anthrones with modulated redox properties. 5. Potent inhibition of human keratinocyte growth, induction of keratinocyte differentiation, and reduced membrane damage by novel 10-arylacetyl-1,8-dihydroxy-9(10H)-anthracenones.
Topics: Acetanilides; Anthracenes; Anti-Inflammatory Agents, Non-Steroidal; Cell Differentiation; Cell Division; Cell Line; Cell Membrane; Humans; Keratinocytes; Leukotriene B4; Oxidation-Reduction; Psoriasis; Structure-Activity Relationship | 2001 |
Hypericins and thioredoxin reductase: Biochemical and docking studies disclose the molecular basis for effective inhibition by naphthodianthrones.
Topics: Amino Acid Sequence; Anthracenes; Inhibitory Concentration 50; Kinetics; Models, Molecular; Molecular Sequence Data; Molecular Structure; Perylene; Sequence Homology, Amino Acid; Thioredoxin-Disulfide Reductase | 2011 |
Phenothiazine, anthraquinone and related tricyclic derivatives as inhibitors of monoamine oxidase.
Topics: Anthraquinones; Dose-Response Relationship, Drug; Humans; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Phenothiazines; Structure-Activity Relationship | 2022 |
[Anthraquinone and anthraquinone glycosides; the synthesis of Chrysazinhydroquinone-1-glycoside and chrysazin-9-anthrone-1-glycoside].
Topics: Anthracenes; Anthraquinones; Glycosides | 1953 |